The medication is indicated for the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.
The beauty retailer laid out priorities to help drive profitable growth and long-term financial targets, which include opening 200 new stores over the next three years.
As chief brand officer, Palmer will serve as a spokesperson and also work with the company consulting on product innovation, packaging evolution and demos.